How Tirzepatide Supports Weight Loss Tirzepatide works by targeting multiple pathways in the body related to glucose and weight regulation
Speaking at the launch, Vikrant Shrotriya, Corporate Vice President and Managing Director, Novo Nordisk India, said Oral semaglutide has a strong clinical profile, we believe, it has the potential to revolutionise the treatment of type 2 diabetes, given that millions of people do not achieve the targeted blood sugar levels with currently available oral antidiabetic medications.Likewise, we believe, semaglutide in oral form will transform the management of diabetes demonstrating our dedication to advancing patient care through continued innovation. Dr Shashank Joshi, Chair IDF Southeast Asia and Consultant Endocrinologist at Lilavati Hospital, Bhatia Hospital and Joshi Clinic, Mumbai said, "Glucagon-like peptide 1 (GLP-1) is a naturally occurring hormone and plays an important role in maintaining the normal level of glucose in the blood
Body weighttumor incidence correlations in long-term rodent carcinogenicity studies
We are dedicated to educating our patients and only recommend specific treatments when we firmly believe they are the right course of action for improving patient health and wellbeing
VK2735 is being developed in both subcutaneous injectable and oral tablet formulations, with the oral form showing competitive weight loss in phase 2 trials
Zoba and Christina M
